DKK1 and cancer: Based on the ability of DKK-1 to inhibit β-catenin-dependent Wnt signaling, a pathway that is frequently dysregulated in cancer cells, DKK-1 has been widely investigated in oncology and is now considered an attractive therapeutic target for anti-cancer therapy5.